Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

83.21
+0.44500.54%
Post-market: 82.04-1.1650-1.40%18:05 EDT
Volume:733.66K
Turnover:61.04M
Market Cap:3.65B
PE:-76.87
High:84.50
Open:82.76
Low:81.95
Close:82.76
52wk High:85.25
52wk Low:48.20
Shares:43.88M
Float Shares:32.68M
Volume Ratio:0.78
T/O Rate:2.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:10.53
PE(LYR):-52.33

Loading ...

Tarsus Pharmaceuticals - Upfront Consideration for Deal Totals $75 Mln: $37.5 Mln Cash, $37.5 Mln Stock

THOMSON REUTERS
·
Jul 09

Tarsus Pharmaceuticals - to Begin Phase 3 Irx-101 Study in H1 2027, Results Expected 2028

THOMSON REUTERS
·
Jul 09

Tarsus Advances Eye Care Leadership Strategy with Acquisition of Irenix Medical and Late-stage Asset Irx-101

THOMSON REUTERS
·
Jul 09

Tarsus Pharmaceuticals - Potential Milestone Payments up to $490 Mln

THOMSON REUTERS
·
Jul 09

Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101

GlobeNewswire
·
Jul 09

Culper Research Says We are Short Tarsus Pharmaceuticals

Reuters
·
Jul 07

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Analysts Offer Insights on Healthcare Companies: BrightSpring Health Services, Inc. (BTSG) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 02

Tarsus Pharmaceuticals Stock Drops as Short Seller Alleges Illegal Copay Scheme

Benzinga
·
Jul 02

Tarsus Pharmaceuticals Faces Medicare Copay Allegations From Culper Research; Shares Fall

MT Newswires Live
·
Jul 02

Tarsus Falls After Short Seller Flags Concerns over Eye Drug

Reuters
·
Jul 02

Culper Research announces Tarsus Pharmaceuticals short position

TIPRANKS
·
Jul 02

Culper Research - We are Short Tarsus Pharmaceuticals

THOMSON REUTERS
·
Jul 02

Tarsus Pharmaceuticals Stockholders Approve Governance and Oversight

TIPRANKS
·
Jun 30

Tarsus Pharmaceuticals Holds Annual Shareholder Meeting

Reuters
·
Jun 30

Tarsus Pharma CEO and Chair Bobak R. Azamian disposes of common shares worth $616,864.54

Reuters
·
Jun 23

Tarsus Pharma Director William J. Link reports $777,809 common share disposal

Reuters
·
Jun 18

Achieve Life Sciences adds Jeffrey Farrow, Reid Waldman to board

Reuters
·
Jun 02

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, Md to Board of Directors

THOMSON REUTERS
·
Jun 02

Evaluating Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 02